MEI Pharma
MEIP
MEIP
31 hedge funds and large institutions have $18.4M invested in MEI Pharma in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 10 reducing their positions, and 2 closing their positions.
Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.45%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
10
Reduced
10
Closed
2
Calls
$3K
Puts
$12K
Net Calls
-$9K
Net Calls Change
+$8.88M
Top Buyers
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
26
Wells Fargo
San Francisco,
California
| $835 | 144 | -9,006 | -98% |
|
27
RhumbLine Advisers
Boston,
Massachusetts
| $707 | 122 | – | – |
|
28
Osaic Holdings
Scottsdale,
Arizona
| $580 | 100 | -2 | -2% |
|
29
JPMorgan Chase & Co
New York
| $308 | 53 | -413 | -89% |
|
30
Qube Research & Technologies (QRT)
London,
United Kingdom
| $12 | 2 | -2 | -50% |
|
|
LCM
31
Laurion Capital Management
New York
| – | – | -128,845 | Closed |
|
32
Simplex Trading
Chicago,
Illinois
| – | – | -24,628 | Closed |
|
|
CFGS
33
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
34
Carson Wealth (CWM LLC)
Omaha,
Nebraska
| $0 | 1 | – | – |
|